Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women’s Health Initiative Randomized Trial

In the Women’s Health Initiative randomized trial evaluating estrogen plus progestin after 5.6 years’ intervention and 8 years’ cumulative median follow-up, there were more lung cancer deaths in the hormone-treated group (P = .01). Now, after 6 years’ additional postintervention follow-up, the incre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lung Cancer
Main Authors: Chlebowski, Rowan T., Wakelee, Heather, Pettinger, Mary, Rohan, Thomas, Liu, Jingmin, Simon, Michael, Tindle, Hilary, Messina, Catherine, Johnson, Karen, Schwartz, Ann, Gass, Margery, Wactawski-Wende, Jean
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6855180/
https://ncbi.nlm.nih.gov/pubmed/26577506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2015.09.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados